Search - tctmd.com

Displaying 1 - 20 of 35

Sort: Relevancy | Date

News Daily News

Patient Complexity Increasing at PCI Sites Without Surgical Backup

Yael L. Maxwell

December 29, 2020

News Daily News

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Michael O'Riordan

December 11, 2020

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

Shelley Wood

November 26, 2020

News Conference News

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

Shelley Wood

November 19, 2020

News Conference News AHA 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Shelley Wood

November 15, 2020

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Daily News

More Risk of Death—All, Cardiac, and Noncardiac—With PCI Over Surgery: Meta-analysis

Michael O'Riordan

October 23, 2020

News Conference News TCT 2020

EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI

L.A. McKeown

October 22, 2020

News Conference News TCT 2020

Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial

Michael O'Riordan

October 17, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Caitlin E. Cox

October 08, 2020

In-Stent Restenosis Accounts for 10% of All PCIs, Contemporary National Analysis Shows

News Daily News

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

L.A. McKeown

September 24, 2020

News Daily News

Hostility After ACS Linked to All-Cause Mortality

Michael O'Riordan

September 21, 2020

News Daily News

PCI Volumes Rise in US and Japan, but for Different Reasons

Michael O'Riordan

September 14, 2020

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Daily News

Missing EXCEL MI Data Published, Prompting New Questions and Promised Answers

Michael O'Riordan

August 07, 2020

News Daily News

Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data

Michael O'Riordan

July 14, 2020

News Conference News EuroPCR 2020

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Michael O'Riordan

June 30, 2020

News Daily News

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

L.A. McKeown

June 29, 2020

Advertisement

Patient Complexity Increasing at PCI Sites Without Surgical Backup

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

More Risk of Death—All, Cardiac, and Noncardiac—With PCI Over Surgery: Meta-analysis

EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI

Fewer Events and Symptoms With iFR-Optimized PCI, Suggests DEFINE-PCI Trial

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

Hostility After ACS Linked to All-Cause Mortality

PCI Volumes Rise in US and Japan, but for Different Reasons

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Missing EXCEL MI Data Published, Prompting New Questions and Promised Answers

Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content